Generic Sterile Injectables Market
According to Intent Market Research, the Generic Sterile Injectables Market is expected to grow from USD 9.9 billion in 2024-e at a CAGR of 12.2% to touch USD 19.7 billion by 2030. The Generic Sterile Injectables Market is dominated by key players such as, Fresenius Kabi, Pfizer Inc., Teva Pharmaceutical Industries Ltd., Cipla Ltd., and Baxter International Inc.